You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Rhodes Jason P · SEC Form 4 · Filed Jun 26, 2026
Sale
Calculated transaction value
$267.95K
Rhodes Jason P Director
DYN
Transaction date
Jun 25, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 1 day later
DYN daily price context
Close on/before transaction
$20.61
Jun 25, 2026
First close after public filing
$21.26
Jun 29, 2026
30-day return after filing
+20.56%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,699 shares @ $21.1
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001577014-26-000010
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$5.65M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN | Sale | Jun 25, 2026 | $105.9K |
| Dyne Therapeutics, Inc. DYN Current | Sale | Jun 25, 2026 | $267.95K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 25, 2026 | $134.66K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 24, 2026 | $533.84K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 24, 2026 | $1.06M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 24, 2026 | $419.83K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 23, 2026 | $1.65M |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 23, 2026 | $650.25K |
| Dyne Therapeutics, Inc. DYN | Sale | Jun 23, 2026 | $826.84K |